Javascript must be enabled to continue!
Structural and functional brain alterations in patients with myasthenia gravis
View through CrossRef
Abstract
Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described. However, little is known about myasthenia gravis-related reorganization of the brain. In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients. Eleven myasthenia gravis patients (age: 70.64 ± 9.27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.18 ± 8.98; 11 males). Most of the patients (n = 10, 0.91%) received cholinesterase inhibitors. Structural brain changes were determined by applying voxel-based morphometry using high-resolution T1-weighted sequences. Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels. Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus. Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.034, d = 1.466), verbal episodic memory (P = 0.003, d = 1.468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.003, d = 1.200). Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.001, d = 2.040). Our results indicate that myasthenia gravis is associated with structural and functional brain alterations. Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions. Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe. Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail.
Title: Structural and functional brain alterations in patients with myasthenia gravis
Description:
Abstract
Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness.
Additionally, systemic inflammation, cognitive deficits and autonomic dysfunction have been described.
However, little is known about myasthenia gravis-related reorganization of the brain.
In this study, we thus investigated the structural and functional brain changes in myasthenia gravis patients.
Eleven myasthenia gravis patients (age: 70.
64 ± 9.
27; 11 males) were compared to age-, sex- and education-matched healthy controls (age: 70.
18 ± 8.
98; 11 males).
Most of the patients (n = 10, 0.
91%) received cholinesterase inhibitors.
Structural brain changes were determined by applying voxel-based morphometry using high-resolution T1-weighted sequences.
Functional brain changes were assessed with a neuropsychological test battery (including attention, memory and executive functions), a spatial orientation task and brain-derived neurotrophic factor blood levels.
Myasthenia gravis patients showed significant grey matter volume reductions in the cingulate gyrus, in the inferior parietal lobe and in the fusiform gyrus.
Furthermore, myasthenia gravis patients showed significantly lower performance in executive functions, working memory (Spatial Span, P = 0.
034, d = 1.
466), verbal episodic memory (P = 0.
003, d = 1.
468) and somatosensory-related spatial orientation (Triangle Completion Test, P = 0.
003, d = 1.
200).
Additionally, serum brain-derived neurotrophic factor levels were significantly higher in myasthenia gravis patients (P = 0.
001, d = 2.
040).
Our results indicate that myasthenia gravis is associated with structural and functional brain alterations.
Especially the grey matter volume changes in the cingulate gyrus and the inferior parietal lobe could be associated with cognitive deficits in memory and executive functions.
Furthermore, deficits in somatosensory-related spatial orientation could be associated with the lower volumes in the inferior parietal lobe.
Future research is needed to replicate these findings independently in a larger sample and to investigate the underlying mechanisms in more detail.
Related Results
Study on the clinical and electrophysiological characteristics of nerve function in myasthenia gravis patients in Vietnam
Study on the clinical and electrophysiological characteristics of nerve function in myasthenia gravis patients in Vietnam
Background: In Vietnam, there is limited research on the role of nerve conduction in myasthenia gravis and its association with clinical features. Objective: This study aims to des...
Management of Myasthenia Gravis through Herbomineral Drug - A Case Study
Management of Myasthenia Gravis through Herbomineral Drug - A Case Study
Ayurveda is an oldest traditional medicine system that believes on natural and holistic approach of treatment for various diseases. It is the science of healthy life. Myasthenia gr...
Thymoma and myasthenia gravis: clinical aspects and prognosis
Thymoma and myasthenia gravis: clinical aspects and prognosis
Myasthenia gravis is present in a significant proportion of patients with thymoma. We investigated particular features of the clinical behavior of thymoma and its relationship to m...
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED]➢Item Name - Gro-X Brain➢ Creation - Natural Organic Compound➢ Incidental Effects - NA➢ Accessibility - Online➢ Rating - ⭐⭐⭐⭐⭐➢ Click Here To Visit - Official Website - ...
Diagnosis of sleepiness, fatigue and depression in patients with myasthenia gravis
Diagnosis of sleepiness, fatigue and depression in patients with myasthenia gravis
Introduction. Examination of excessive daytime sleepiness, fatigue and depression in patients with myasthenia gravis is important for differential diagnosis of other disorders, and...
A case report on primigravida with myasthenia gravis: outcome of pregnancy
A case report on primigravida with myasthenia gravis: outcome of pregnancy
Primigravida refers to a woman who is pregnant for the first time. It is a unique experience for the woman. Usually, any minor alignment during this time will lead to anxiety. The...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Challenges managing myasthenia gravis: an international perspective
Challenges managing myasthenia gravis: an international perspective
There have been increasing breakthroughs in the diagnosis and treatment of myasthenia gravis over the past decades. However, most published research in myasthenia is conducted in d...

